AU5483600A - Pharmaceutical materials and methods for their preparation and use - Google Patents

Pharmaceutical materials and methods for their preparation and use

Info

Publication number
AU5483600A
AU5483600A AU54836/00A AU5483600A AU5483600A AU 5483600 A AU5483600 A AU 5483600A AU 54836/00 A AU54836/00 A AU 54836/00A AU 5483600 A AU5483600 A AU 5483600A AU 5483600 A AU5483600 A AU 5483600A
Authority
AU
Australia
Prior art keywords
preparation
methods
pharmaceutical materials
pharmaceutical
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54836/00A
Inventor
Jean A. Chmielewski
Bart E. Kahr
Jerry Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU5483600A publication Critical patent/AU5483600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
AU54836/00A 1999-06-11 2000-06-12 Pharmaceutical materials and methods for their preparation and use Abandoned AU5483600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13891299P 1999-06-11 1999-06-11
US60138912 1999-06-11
PCT/US2000/016140 WO2000076480A2 (en) 1999-06-11 2000-06-12 Pharmaceutical materials and methods for their preparation and use

Publications (1)

Publication Number Publication Date
AU5483600A true AU5483600A (en) 2001-01-02

Family

ID=22484233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54836/00A Abandoned AU5483600A (en) 1999-06-11 2000-06-12 Pharmaceutical materials and methods for their preparation and use

Country Status (3)

Country Link
EP (1) EP1189599A2 (en)
AU (1) AU5483600A (en)
WO (1) WO2000076480A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
US7138262B1 (en) 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
RS52459B (en) 2006-02-07 2013-02-28 Shire Human Genetic Therapies Inc. Stabilized composition of glucocerebrosidase
ES2668079T3 (en) 2009-07-28 2018-05-16 Shire Human Genetic Therapies Compositions and methods to treat Gaucher's disease
CA2865614A1 (en) 2012-03-02 2013-09-06 Shire Human Genetic Therapies, Inc. Compositions and methods for treating type iii gaucher disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306250A1 (en) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen SPHERICAL SINGLE CRYSTALS FOR PHARMACEUTICAL PURPOSES
NL194389C (en) * 1984-06-14 2002-03-04 Novartis Ag Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier.
DE3882011T2 (en) * 1987-10-27 1993-09-30 Fujitsu Ltd Method and device for producing biopolymer single crystal.
US5075291A (en) * 1989-11-22 1991-12-24 Ici Americas Inc. Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
GB9411129D0 (en) * 1993-06-16 1994-07-27 Ici America Inc A crystalline polyol composition
FR2742164B1 (en) * 1995-12-11 1999-01-29 Beghin Say Eridania MICROCRYSTALLINE SUGAR: COMPOSITION AND METHOD OF OBTAINING

Also Published As

Publication number Publication date
EP1189599A2 (en) 2002-03-27
WO2000076480A2 (en) 2000-12-21
WO2000076480A9 (en) 2002-07-11
WO2000076480A3 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU5326100A (en) Pharmaceutical compositions and methods for use
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU5565099A (en) Pharmaceutical compositions and methods for use
AU3159000A (en) Phosphorus-comprising materials, their preparation and use
AU4328800A (en) Pharmaceutical formulation
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU4293800A (en) Cosmetic and/or pharmaceutical preparations
AU5875700A (en) Pigment materials and their preparation and use
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU5483600A (en) Pharmaceutical materials and methods for their preparation and use
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU1688099A (en) Pharmaceutical preparation
AU3839900A (en) Pharmaceutical formulation
AU4543500A (en) Pharmaceutical compositions and uses
AU2880699A (en) Pharmaceutical compositions and methods for use
AU7681498A (en) Pharmaceutical composition and use thereof
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase